Founded in 1999, ChineseInvestors.com has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
- 18-year operator of premier financial information website
Highly diversified revenue streams contribute to growth
Aims to be a recognizable leader in hemp-based CBD oil industry
Developed Chinese language app for cannabis industry
Raising awareness via investor conferences, road shows
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been ¬widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX launched the world's first online CBD health products store published in the Chinese language. www.ChineseCBDoil.com caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. Through its new site, CIIX plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused mobile app, Da Ma Dian Ping, is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
CBD (Cannabidiol) is the natural ingredient extracted from the hemp plant. It is harmless, and non-psychotoxic, contains excellent medical value, and is not an addictive substance. CBD benefits nearly every organ in the human body, and can also improve mental and physical balance.
CBD can be used to make a variety of CBD oil health care products, including spray, capsule, purified liquid, balm, drops and etc. CBD oil products can also be made in different tastes and level of concentration according to the requirements of consumers.
CBD oil is widely known and accepted in North America. It can be used legally in the 50 states of America, and can be exported to 40 countries, including China.
CBD does not have severely negative effects on neurocognitive system. On the contrary, it has the ability of anti-anxiety, pressure relief and etc. Besides, it also help to prevent epilepsy, Alzheimer's disease, liver cirrhosis and other health conditions.
Founded in 1999, CIIX operates under the guidance of a visionary management team with a keen ability to identify and act on value-enhancing opportunities. With a longstanding track record as a leading financial information website for Chinese-speaking investors in the United States and China, CIIX's management applies the same fortitude to grow the company's new online and retail distribution business, with plans to also invest in hemp-based CBD oil drug research and development enterprises in China.
150 N Santa Anta Ave, Suite 300
Arcadia, CA 91006
Phone: (800) 958-8561
1324 Lexington Ave.
New York, NY 10128
Phone: (212) 418-1217
NetworkNewsWire is a moderator of this board. Please see disclaimer on the NetworkNewsWire website: https://www.networknewswire.com/disclaimer/